METHOD FOR OBTAINING CERULOPLASMIN

FIELD: medicine. SUBSTANCE: the present innovation deals with technology to obtain medicinal preparations out of human blood plasma. Residue of VI-1 alcoholic fraction of blood plasma should be homogenized by special technique in sodium chloride solution followed by thermal denaturation of protein a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PISKAREVA JU.K, KRAJNOVA T.A, EFREMOVA L.M, ANASTASIEV V.V
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PISKAREVA JU.K
KRAJNOVA T.A
EFREMOVA L.M
ANASTASIEV V.V
description FIELD: medicine. SUBSTANCE: the present innovation deals with technology to obtain medicinal preparations out of human blood plasma. Residue of VI-1 alcoholic fraction of blood plasma should be homogenized by special technique in sodium chloride solution followed by thermal denaturation of protein admixtures, sorption of obtained solution upon DEAE-cellulose, elution with sodium chloride solution at concentration being 0.1 M, not higher, precipitation of admixtures with ethanol and chloroform mixture, their separation with centrifuging, precipitation of target product with ethanol, dissolving the residue, sterilizing filtration, pasteurization and lyophilic drying of ceruloplasmin solution. At the stage of dissolving the residue of target product one should add mannitol into solution at the quantity of 0.05-0.15 mg/ml protein that enables to obtain preparation of high enzymatic activity being 12 U/mg, not less. EFFECT: higher efficiency. 2 ex
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2225725C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2225725C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2225725C23</originalsourceid><addsrcrecordid>eNrjZFDydQ3x8HdRcPMPUvB3CnH09PP0c1dwdg0K9fEP8HEM9vX042FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8UGhRkZGpuZGps5GxkQoAQADbiJO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR OBTAINING CERULOPLASMIN</title><source>esp@cenet</source><creator>PISKAREVA JU.K ; KRAJNOVA T.A ; EFREMOVA L.M ; ANASTASIEV V.V</creator><creatorcontrib>PISKAREVA JU.K ; KRAJNOVA T.A ; EFREMOVA L.M ; ANASTASIEV V.V</creatorcontrib><description>FIELD: medicine. SUBSTANCE: the present innovation deals with technology to obtain medicinal preparations out of human blood plasma. Residue of VI-1 alcoholic fraction of blood plasma should be homogenized by special technique in sodium chloride solution followed by thermal denaturation of protein admixtures, sorption of obtained solution upon DEAE-cellulose, elution with sodium chloride solution at concentration being 0.1 M, not higher, precipitation of admixtures with ethanol and chloroform mixture, their separation with centrifuging, precipitation of target product with ethanol, dissolving the residue, sterilizing filtration, pasteurization and lyophilic drying of ceruloplasmin solution. At the stage of dissolving the residue of target product one should add mannitol into solution at the quantity of 0.05-0.15 mg/ml protein that enables to obtain preparation of high enzymatic activity being 12 U/mg, not less. EFFECT: higher efficiency. 2 ex</description><edition>7</edition><language>eng ; rus</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040320&amp;DB=EPODOC&amp;CC=RU&amp;NR=2225725C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040320&amp;DB=EPODOC&amp;CC=RU&amp;NR=2225725C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PISKAREVA JU.K</creatorcontrib><creatorcontrib>KRAJNOVA T.A</creatorcontrib><creatorcontrib>EFREMOVA L.M</creatorcontrib><creatorcontrib>ANASTASIEV V.V</creatorcontrib><title>METHOD FOR OBTAINING CERULOPLASMIN</title><description>FIELD: medicine. SUBSTANCE: the present innovation deals with technology to obtain medicinal preparations out of human blood plasma. Residue of VI-1 alcoholic fraction of blood plasma should be homogenized by special technique in sodium chloride solution followed by thermal denaturation of protein admixtures, sorption of obtained solution upon DEAE-cellulose, elution with sodium chloride solution at concentration being 0.1 M, not higher, precipitation of admixtures with ethanol and chloroform mixture, their separation with centrifuging, precipitation of target product with ethanol, dissolving the residue, sterilizing filtration, pasteurization and lyophilic drying of ceruloplasmin solution. At the stage of dissolving the residue of target product one should add mannitol into solution at the quantity of 0.05-0.15 mg/ml protein that enables to obtain preparation of high enzymatic activity being 12 U/mg, not less. EFFECT: higher efficiency. 2 ex</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDydQ3x8HdRcPMPUvB3CnH09PP0c1dwdg0K9fEP8HEM9vX042FgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8UGhRkZGpuZGps5GxkQoAQADbiJO</recordid><startdate>20040320</startdate><enddate>20040320</enddate><creator>PISKAREVA JU.K</creator><creator>KRAJNOVA T.A</creator><creator>EFREMOVA L.M</creator><creator>ANASTASIEV V.V</creator><scope>EVB</scope></search><sort><creationdate>20040320</creationdate><title>METHOD FOR OBTAINING CERULOPLASMIN</title><author>PISKAREVA JU.K ; KRAJNOVA T.A ; EFREMOVA L.M ; ANASTASIEV V.V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2225725C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2004</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PISKAREVA JU.K</creatorcontrib><creatorcontrib>KRAJNOVA T.A</creatorcontrib><creatorcontrib>EFREMOVA L.M</creatorcontrib><creatorcontrib>ANASTASIEV V.V</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PISKAREVA JU.K</au><au>KRAJNOVA T.A</au><au>EFREMOVA L.M</au><au>ANASTASIEV V.V</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR OBTAINING CERULOPLASMIN</title><date>2004-03-20</date><risdate>2004</risdate><abstract>FIELD: medicine. SUBSTANCE: the present innovation deals with technology to obtain medicinal preparations out of human blood plasma. Residue of VI-1 alcoholic fraction of blood plasma should be homogenized by special technique in sodium chloride solution followed by thermal denaturation of protein admixtures, sorption of obtained solution upon DEAE-cellulose, elution with sodium chloride solution at concentration being 0.1 M, not higher, precipitation of admixtures with ethanol and chloroform mixture, their separation with centrifuging, precipitation of target product with ethanol, dissolving the residue, sterilizing filtration, pasteurization and lyophilic drying of ceruloplasmin solution. At the stage of dissolving the residue of target product one should add mannitol into solution at the quantity of 0.05-0.15 mg/ml protein that enables to obtain preparation of high enzymatic activity being 12 U/mg, not less. EFFECT: higher efficiency. 2 ex</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2225725C2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title METHOD FOR OBTAINING CERULOPLASMIN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A29%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PISKAREVA%20JU.K&rft.date=2004-03-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2225725C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true